查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511803

RNAi 技术市场规模、份额、趋势分析报告：按产品/服务、应用、最终用途、地区和细分市场进行预测，2024-2030 年

RNAi Technology Market Size, Share & Trends Analysis Report By Product & Services (Products, Services), By Application (Drug Discovery & Development, Functional Genomics), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

RNAi技术市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球RNAi技术市场规模将达到66.5亿美元，2024年至2030年复合年增长率为14.6%。

预计在预测期内，技术进步以及药物发现和药物开发应用的增加将增加对 RNAi 技术的需求。

COVID-19 大流行对市场产生了积极影响。开发针对 COVID-19 的有效治疗方法和疫苗的迫切需求导致对基于 RNA 的技术（包括 RNAi）的资金和投资激增。各国政府、製药公司和生技公司在RNA研究上投入大量资金，加速了RNAi疗法的开发和商业化。因此，在预测期内对 RNAi 技术的需求正在增加。

此外，政府对医疗保健的投资增加预计将在预测期内推动市场成长。各国政府和相关组织正在努力透过推广生物製药治疗来最大限度地减少感染疾病的医疗支出。国际医疗保健组织正在帮助提高意识并发现各种疾病的新治疗方法。增加用于临床研究的外部资金以引入新的药物治疗对于产品开发至关重要。政府主导正在推动市场扩张。

然而，欠发达国家严重缺乏熟练的专业人员和研究支持，这对其进入动态市场的能力产生了重大影响。教育差距和持续培训机会的缺乏加剧了训练有素的劳动力的缺乏。同时，有限的研究经费、基础设施不足和监管复杂性阻碍了这些地区的科学进步。预计这将阻碍预测期内的市场成长。

RNAi 技术市场报告亮点

  • 2023年的产品和服务市场中，产品部门占收益占有率最高。产品细分又分为miRNA、siRNA等。这是由于产品的高渗透率和套件和试剂的高使用率。同时，服务业预计将在预测期内以最快的速度成长。
  • 按应用来看，药物发现和药物开发领域预计将在2023年占据最大的市场占有率，达到68.87%，并在预测期内以最快的速度成长。这是由于对新药的需求不断增加和技术进步不断扩大。
  • 根据最终用途，製药和生物技术公司在该领域占据主导地位，2023 年收益占有率最高，达到 56.54%。另一方面，CRO&CMO 预计在预测期内将以最快的复合年增长率成长。
  • 由于强大的医疗基础设施、先进医疗技术的高采用率以及对生物製药研发的大量投资，北美地区在 2023 年将占据 38.54% 的市场占有率。同时，亚太地区预计在预测期内将以最高的复合年增长率成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章 市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第 4 章 RNAi 技术市场：产品与服务的商业分析

  • 产品和服务细分仪表板
  • 全球RNAi技术市场产品与服务波动分析
  • 2018-2030年全球RNAi技术市场规模与趋势分析（依产品与服务）
  • 产品
  • 服务

第五章RNAi技术市场：应用商业分析

  • 使用细分仪表板
  • 全球RNAi技术市场应用与波动分析
  • 2018-2030年全球RNAi技术市场规模及趋势分析（依应用）
  • 药物发现与开发
  • 功能基因体学
  • 其他的

第六章 RNAi 技术市场：最终用途业务分析

  • 最终用途细分仪表板
  • 全球RNAi技术市场的最终用途变化分析
  • 2018-2030 年全球 RNAi 技术市场规模与趋势分析（依最终用途）
  • 製药和生物技术公司
  • 学术研究所
  • 合约研究官（CRO）和首席行销长（CMO）

第 7 章 RNAi 技术市场：按产品/服务、应用和最终用途进行区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模及预测及趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章 竞争格局

  • 参与企业
  • 策略规划
  • 2023 年企业市场分析
  • 参与企业概况
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • Creative Biolabs
    • GenScript
    • Revvity
    • Promega Corporation
    • OriGene Technologies, Inc.
    • Altogen Biosystems
    • Danaher
    • Bioneer Corporation

第九章 分析师观点

Product Code: GVR-4-68040-295-6

RNAi Technology Market Growth & Trends:

The global RNAi technology market size is anticipated to reach USD 6.65 billion by 2030 and is growing at a CAGR of 14.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing technological advancements and increasing applications in drug discovery and development are anticipated to increase the demand for RNAi technology over the forecast period.

The COVID-19 pandemic has had a positive impact on the market. The urgency to develop effective treatments and vaccines for COVID-19 led to a surge in funding and investments in RNA-based technologies, including RNAi. Governments, pharmaceutical companies, and biotech firms invested heavily in RNA research, accelerating the development and commercialization of RNAi therapies. This has increased the demand for RNAi technologies during the forecast period.

Moreover, growing government investments in healthcare are anticipated to fuel market growth over the forecast period. The government and relevant bodies are taking efforts to minimize healthcare expenditure on infectious diseases by promoting biopharmaceutical treatments. International healthcare institutions contribute to raising awareness and the discovery of new therapies for various disorders. Increasing external funding for clinical studies to introduce new drug treatments is pivotal for product development. Government-led initiatives to expedite the development of drug delivery platforms for reducing disease burden are driving market expansion.

However, undeveloped countries have a substantial shortage of skilled professionals and research support, profoundly impacting their participation in the dynamic market. The scarcity of a well-trained workforce is exacerbated by educational disparities and a lack of continuous training opportunities. Simultaneously, limited research funding, infrastructure shortcomings, and regulatory complexities impede scientific progress in these regions. This is anticipated to hamper the market's growth over the forecast period.

RNAi Technology Market Report Highlights:

  • The products segment dominated the product & services market with the highest revenue share in 2023. The product segment is further segmented into miRNA, siRNA, and others. This is attributed to the high product penetration and high usage of kits & reagents. On the other hand, services are expected to grow at the fastest rate over the forecast period
  • The drug discovery & development segment held the largest market share of 68.87% in 2023 for the application segment and is anticipated to grow at the fastest rate over the forecast period. This is attributed to the increasing demand for new drugs and growing technological advancements
  • Based on end-use, pharmaceutical & biotechnology companies dominated the segment with the largest revenue share of 56.54% in 2023. On the other hand, CROs & CMOs are anticipated to grow at the fastest CAGR over the forecast period
  • The North American region dominated the market share of 38.54% in 2023 due to its robust healthcare infrastructure, high adoption rates of advanced medical technologies, and significant investments in biopharmaceutical research and development. On the other hand, Asia Pacific anticipated growing at the highest CAGR over the forecast period

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service
    • 1.2.2. Application
    • 1.2.3. End-use
    • 1.2.4. Region
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing applications of RNAi technology in research and medicine
      • 3.2.1.2. Growing interest in personalized medicine
      • 3.2.1.3. Technological advancements in RNAi techniques
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of skilled professionals and research support in developing countries
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. RNAi Technology Market: Product & Service Business Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. Global RNAi Technology Market Product & Service Movement Analysis
  • 4.3. Global RNAi Technology Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
  • 4.4. Products
    • 4.4.1. Global Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. miRNA
      • 4.4.2.1. Global miRNA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. siRNA
      • 4.4.3.1. Global siRNA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Global Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. RNAi Technology Market: Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global RNAi Technology Market Application, Movement Analysis
  • 5.3. Global RNAi Technology Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Drug Discovery & Development
    • 5.4.1. Global Drug Discovery & Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Neurology
      • 5.4.2.1. Global Neurology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Oncology
      • 5.4.3.1. Global Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Infectious Diseases
      • 5.4.4.1. Global Infectious Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.5. Metabolic Diseases
      • 5.4.5.1. Global Metabolic Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.6. Others
      • 5.4.6.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Functional Genomics
    • 5.5.1. Global Functional Genomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. RNAi Technology Market: End-use Business Analysis

  • 6.1. End-use Segment Dashboard
  • 6.2. Global RNAi Technology Market End-use Movement Analysis
  • 6.3. Global RNAi Technology Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Academic & Research Institutes
    • 6.5.1. Global Academic & Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. CROs & CMOs
    • 6.6.1. Global CROs & CMOs Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. RNAi Technology Market: Regional Estimates & Trend Analysis by Product & Services, Application, End-use

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. North America RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Australia RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Thailand RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. South Korea RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait RNAi Technology Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Participant's Overview
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Merck KGaA
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Creative Biolabs
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. GenScript
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Revvity
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Promega Corporation
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. OriGene Technologies, Inc.
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Altogen Biosystems
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Danaher
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Bioneer Corporation
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

Chapter 9. Analyst View

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 4 Global RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 Global RNAi technology market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America RNAi technology market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 9 North America RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 10 North America RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 U.S. RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 12 U.S. RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 13 U.S. RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 Canada RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 15 Canada RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 16 Canada RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 Mexico RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 18 Mexico RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 19 Mexico RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Europe RNAi technology market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 22 Europe RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 23 Europe RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 UK RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 25 UK RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 26 UK RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Germany RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 28 Germany RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 29 Germany RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 France RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 31 France RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 32 France RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Italy RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 34 Italy RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 35 Italy RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Spain RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 37 Spain RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 38 Spain RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Denmark RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 40 Denmark RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 41 Denmark RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Sweden RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 43 Sweden RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 44 Sweden RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Norway RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 46 Norway RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 47 Norway RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific RNAi technology market, by country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Japan RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 53 Japan RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 54 Japan RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 China RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 56 China RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 57 China RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 India RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 59 India RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 60 India RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Australia RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 62 Australia RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 63 Australia RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Thailand RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 65 Thailand RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 66 Thailand RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 South Korea RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 68 South Korea RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 69 South Korea RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 Latin America RNAi technology market, by country, 2018 - 2030 (USD Million)
  • Table 71 Latin America RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 72 Latin America RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 73 Latin America RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 Brazil RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 75 Brazil RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 76 Brazil RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 77 Argentina RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 78 Argentina RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 79 Argentina RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa RNAi technology market, by country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 84 South Africa RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 85 South Africa RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 86 South Africa RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 UAE RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 91 UAE RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 92 UAE RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait RNAi technology market, by product & service, 2018 - 2030 (USD Million)
  • Table 94 Kuwait RNAi technology market, by application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait RNAi technology market, by end-use, 2018 - 2030 (USD Million)
  • Table 96 Participant's overview
  • Table 97 Financial performance
  • Table 98 Key companies undergoing expansions
  • Table 99 Key companies undergoing acquisitions
  • Table 100 Key companies undergoing collaborations
  • Table 101 Key companies launching new products
  • Table 102 Key companies undertaking other strategies

List of Figures

  • Fig. 1 RNAi technology market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 RNAi technology market driver analysis
  • Fig. 12 RNAi technology market restraint analysis
  • Fig. 13 RNAi technology market: Porter's analysis
  • Fig. 14 RNAi technology market: PESTEL analysis
  • Fig. 15 RNAi technology market: Product & service outlook and key takeaways
  • Fig. 16 RNAi technology market: Product & service market share analysis, 2023 - 2030
  • Fig. 17 Global RNAi technology by products market, 2018 - 2030 (USD Million)
  • Fig. 18 Global RNAi technology by miRNA market, 2018 - 2030 (USD Million)
  • Fig. 19 Global RNAi technology by siRNA market, 2018 - 2030 (USD Million)
  • Fig. 20 Global RNAi technology by others market, 2018 - 2030 (USD Million)
  • Fig. 21 Global RNAi technology by service market, 2018 - 2030 (USD Million)
  • Fig. 22 RNAi technology market: Application outlook and key takeaways
  • Fig. 23 RNAi technology market: Application market share analysis, 2023 - 2030
  • Fig. 24 Global RNAi technology by drug discovery & dvelopment market, 2018 - 2030 (USD Million)
  • Fig. 25 Global RNAi technology by neurology market, 2018 - 2030 (USD Million)
  • Fig. 26 Global RNAi technology by oncology market, 2018 - 2030 (USD Million)
  • Fig. 27 Global RNAi technology by infectious diseases market, 2018 - 2030 (USD Million)
  • Fig. 28 Global RNAi technology by metabolic diseases market, 2018 - 2030 (USD Million)
  • Fig. 29 Global RNAi technology by others market, 2018 - 2030 (USD Million)
  • Fig. 30 Global RNAi technology by functional genomics market, 2018 - 2030 (USD Million)
  • Fig. 31 Global RNAi technology others market, 2018 - 2030 (USD Million)
  • Fig. 32 RNAi technology market: End-use outlook and key takeaways
  • Fig. 33 RNAi technology market: End-use market share analysis, 2023 - 2030
  • Fig. 34 Global RNAi technology by pharmaceutical & biotechnology companies market, 2018 - 2030 (USD Million)
  • Fig. 35 Global RNAi technology by academic & research institutes market, 2018 - 2030 (USD Million)
  • Fig. 36 Global RNAi technology by CROs & CMOs market, 2018 - 2030 (USD Million)
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 North America RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Canada RNAi technology market, 2018 - 2030 (USD Million)
  • Fig. 41 Mexico RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Europe RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 UK RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Germany RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 France RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Italy RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Spain RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Norway RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Japan RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 China RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 India RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Australia RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Thailand RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 MEA RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 South Africa RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Saudi Arabia RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 UAE RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait RNAi technology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Key company categorization
  • Fig. 67 Company market positioning
  • Fig. 68 Market participant categorization
  • Fig. 69 Strategy framework